Related Experiment Video
Updated: Jul 31, 2026
07:49
Measuring Local Anaphylaxis in Mice
Published on: October 14, 2014
Update on urticaria and angioedema (hives)
1Division of Allergy and Immunology, University of South Florida Health Sciences Center, Tampa, USA.
Allergy Proceedings : the Official Journal of Regional and State Allergy Societies
|November 1, 1995
Summary
New research explores severe chronic hives (urticaria) unresponsive to standard treatments. A specific autoantibody (IgG against IgE receptor) is identified, leading to increased use of immunomodulating agents for better patient outcomes.
Area of Science:
- Immunology
- Dermatology
Background:
- Urticaria is a common skin condition.
- Severe chronic urticaria often resists conventional therapies.
Purpose of the Study:
- To update on new concepts in urticaria pathogenesis.
- To review novel treatments for severe, refractory hives.
Main Methods:
- Literature review of recent advancements.
- Identification of novel autoantibodies.
- Analysis of emerging treatment strategies.
Main Results:
- A novel autoantibody, IgG against the IgE receptor, is identified in some severe chronic urticaria patients.
- Anti-inflammatory and immunomodulating agents show promise.
Conclusions:
- Understanding of urticaria pathogenesis is evolving.
- New therapeutic approaches are emerging for difficult-to-treat chronic idiopathic urticaria (CIU).
Related Concept Videos
02:06Allergic Reactions
Overview
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...